SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 earnings report is the main focus, with traders watching guidance, subscriber engagement and advertising growth after a steep share-price decline and recent layoffs and content-leadership changes. Views are split between hopes for a rebound if results or outlook exceed subdued expectations and bets on further losses if growth concerns persist.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is tied to enthusiasm for its Merck-partnered personalized melanoma vaccine after positive Phase 3 topline results, with traders focused on the detailed data presentation at ESMO. Bulls see validation of a broader cancer-vaccine platform and momentum, while bears argue expectations and valuation are stretched and warn of a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Traders are citing a reported ClinicalTrials.gov update adding a site to Sareptas ENHANCE Elevidys safety study as a possible trigger for the rebound, though they note the study timeline reportedly slipped. The broader debate centers on whether upcoming DM1 and FSHD data can support a recovery, with some traders pointing to short covering and others stressing that those clinical results remain unproven.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas sharp selloff and fresh low are being linked by traders to plans for a potential Monee listing and the launch of Sea Cloud, alongside concerns about spending and competition in e-commerce. Some see a Monee separation as value-unlocking, while others view the plans and uncertainty around them as a reason to sell; claims of further undisclosed bad news remain speculation.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and higher outlook have been met with a sharp selloff, prompting traders to question why strong demand and orders are not lifting the shares. The debate centers on rising costs, weaker cash conversion and an insurance loss, while some investors view the reaction as excessive given the improved guidance.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention after its quarterly earnings beat and improved cash-flow outlook failed to prevent a sharp selloff, as traders focused on narrowed full-year profit guidance with no increase to its midpoint. Some see the new buyback and cash generation as support for the shares, while others argue the outlook disappointed despite the strong quarter.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash proceeds as a potential balance-sheet and strategic reset. Others argue the divestiture removes a significant revenue stream and leaves concerns about debt and weakness in the remaining business; the transaction is still pending approval and closing.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel data in progressive MS and additional BRIUMVI results, with commercial growth and a future subcutaneous formulation also part of the bullish case. Traders are anticipating a catalyst-driven move, though some caution that the azer-cel results remain uncertain and complain that the shares have struggled to break out of a trading range.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

A sharp COMP rally has sparked breakout talk, with traders pointing to rising momentum, chart patterns, and the tokens limited supply; others remain skeptical, calling it a volatile bounce and questioning whether gains can hold.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

RAP-219s Phase 2 trial in bipolar mania met its primary and secondary endpoints, prompting bullish trading and analyst optimism, including an upgrade. The community is divided over the modest placebo-adjusted benefit and concerns about agitation and discontinuations; the initial surge faded as traders debated whether the data justify further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tom Lee’s Ethereum Year-End Call Is Now Half Of What He Called ‘Conservative’ Last Month, But He Expects ‘Monster Moves’ In The Crypto Industry

Cryptocurrency

Tom Lee tied the nearer call to BTC, saying ETH should reach about $7,500 if Bitcoin hits $100,000.


BMNR Stock Gains Alongside Ethereum After Tom Lee's BitMine Makes One Of Its Smallest Ethereum Purchases Ever

Equity

Chairman Tom Lee said the company carried out what he described as the largest crypto treasury equity buyback. 

BMNR Stock Forms Golden Cross For First Time Since Bitmine’s Ethereum Pivot Rally 

The last time the 50-day line crossed above the 200-day was more than a year ago, when the company pivoted to buying Ethereum. 


Tom Lee Says ETH Could Top $10,000 In The Next 12 Months, Calls Arthur Hayes' Year-End Target 'Conservative'

Tom Lee said crypto treasury companies could ramp up buying over the next 12 to 18 months, potentially tightening ETH supply. 

Tom Lee Says ‘Stay Tuned’ As Bitmine Nears 5% Ethereum Goal, Hints At What’s Next

Tom Lee-backed Bitmine now holds 4.9% of the supply of all the Ethereum in circulation.


Tom Lee Says Crypto Is A 'Huge Winner' As Banks Move Toward Tech-Style Valuations, While Dan Ives Calls AI A 'Two-Horse Race'

Fundstrat picked JP Morgan as a core buy and Robinhood, Galaxy Digital, and Riot Platforms as bottom five recommendations, cautious on crypto-sensitive stocks.

Tom Lee's BMNR Adds 1 BTC, Expands ORBS Stake By $7M Amid Ethereum Buying Spree

BitMine expanded its crypto and equity holdings while keeping its focus on building a 5% stake in Ethereum. 

BMNR Stock Dips Even As Its Latest Ethereum Buy Leaves It Just 0.1% From Its 'Alchemy Of 5%' Goal

Bitmine chairman Tom Lee said BMNR stock was the fourth-best performer in the Russell 1000, setting “the stage for institutions to add to their crypto holdings.”


BitMine Makes Biggest Weekly Ethereum Purchase Since June, Adding Over 50K ETH To Its Stash

BitMine stepped up its Ethereum buying as it moved close to controlling 5% of ETH’s total supply.


Tom Lee-Led BitMine Reportedly Scoops Up $48.89 Million Of Ethereum During Crypto’s ‘AI Downstream’ Story

Bitcoin dominance remains above 60%, which a crypto commentator says leaves a broader altcoin rotation unconfirmed.


ETF Opportunities Trust - T-REX 2X Long BMNR Daily Target ETF

Bearish Sentiment

<ul class="summary-bullets"><li>BitMine Immersion Technologies chairman Tom Lee said <a class="mention" data-mention="$ETH.X" data-symbol-id="ETH.X" href="https://stocktwits.com/symbol/ETH.X" target="_blank">Ethereum</a> should top $5,000 by year-end, in Singapore on Friday.</li><li>That was half the $10,000 year-end figure Lee called "conservative" when he also said Ethereum would trade "much higher" than that level within 12 months.</li><li>His cycle target came down too, to "25,000 or 50,000 per token" from an illustrative $62,000 nine days earlier.</li></ul><p>Ethereum (ETH) held above $2,400 on Saturday after BitMine Immersion Technologies (BMNR) chairman Tom Lee said the token should top $5,000 by year-end, half the level he called a “conservative target” more than a week ago.</p><p>Speaking at&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=xyGoVLlpnDY">Token 2049</a> in Singapore on Friday, Lee, who is also co-founder and head of research at Fundstrat, tied the call to Bitcoin (BTC). If Bitcoin climbs to $100,000, he said, Ethereum should trade around $7,500. That was a step down from what he called FLOP Labs’ CEO Arthur Hayes’ $10,000 year-end prediction for&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/tom-lee-says-eth-could-top-10-000-in-the-next-12-months-calls-arthur-hayes-year-end-target-conservative/cZMF2mYRBha">Ethereum “conservative</a>,” last month.</p><p>Then, with Ethereum near $2,670, he said the token would see “much higher prices than 10,000” within 12 months. To support his point, Lee said, “Think Arthur's conservative in the sense that you know in the past cycles Ethereum has gone up 50 times to 200 times.”</p><p>On Friday, the cycle number was lower too. Ethereum “could easily be 25,000 or 50,000 per token,” he said.&nbsp;</p><h2 class="st-heading-2">Still Calling It Undervalued</h2><p>Lee called the token “massively undervalued,” pointing to years of sideways trading. The longer the base, he said, the bigger the breakout. The market, however, shows something different. Bitcoin’s (BTC) dominance has risen to about 57.5%, while Ethereum’s sat near 10.5%.</p><p><a href="https://stocktwits.com/coins/ethereum">Ethereum’s price</a> traded relatively flat over the past 24 hours. On Stocktwits, retail sentiment around Ethereum remained in the ‘bearish’ zone, with chatter at ‘normal’ levels over the last day.</p><h2 class="st-heading-2">Why This Cycle Is Different</h2><p>Lee argued this cycle will outrun past ones because of who was buying. Earlier rallies ran on retail money, first through initial coin offerings and later through non-fungible tokens (NFTs). This time, he said, institutions were building real products on blockchains. Investors “aren’t bullish enough,” he said, and should expect “some monster moves in crypto prices.”</p><h2 class="st-heading-2">Why BitMine Bets On Ethereum</h2><p>Lee pointed to Ethereum’s developer base and its record without downtime. He also warned large banks that ignore crypto. He said firms that fail to build a crypto strategy risk becoming "the National Cash Register (NCRs) and the Microwave Communications, Inc. (MCIs) of this era," referring to two companies he said missed major technology shifts.&nbsp;</p><p><a href="https://stocktwits.com/symbol/BMNR">BMNR stock</a> closed little changed on Friday. On Stocktwits, retail sentiment around BMNR remained in the ‘bearish’ zone, with chatter at ‘normal’ levels over the past day.</p><p><strong>Read also:&nbsp;</strong><a href="https://stocktwits.com/news-articles/markets/cryptocurrency/aave-jumps-after-citrini-research-bets-defi-tokens-tokenization/cZxTtbZRBnM"><strong>AAVE Jumps After Citrini Research Bets On DeFi Tokens’ $157T Tokenization Opportunity</strong></a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Tom Lee, the chairman of BitMine, speaks during the Fan Meetup at World Flagship Space Seoul on September 25, 2025 in Seoul, South Korea. (Photo by Myunggu Han/Getty Images for BitMine

Ethereum (ETH) held above $2,400 on Saturday after BitMine Immersion Technologies (BMNR) chairman Tom Lee said the token should top $5,000 by year-end, half the level he called a “conservative target” more than a week ago.

Tom Lee’s Ethereum Year-End Call Is Now Half Of What He Called ‘Conservative’ Last Month

BitMine Immersion Technologies Inc

T-REX 2X Long BMNR Daily Target ETF

iShares Ethereum Trust ETF

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Stocktwits Polls

$BMNU Trade your plan. Did I? No. Got short at $24 and wanted to cover at $18. Well, it’s $18 (ish).
Covered at $21. BOOOOO!!!!
Now, sadly, I believe we retest $16 if this pressure keeps up.

Fume Baby

$BMNU I was ful leverage to point where got margin call and ignored in assx mstx and this I might not have to work again 😂😂😂

James

$BMNU I feel like this was obvious play but at the same time a risky play considering btc closed leaning bearish 
But it was below nav and not equal to eth price but if you bought the dip you could have gotten wrecked like we did yesterday

$BMNU damn was holding thousands of shares overnight with some revenge trading at the bottom only down 350$ on day that sucked last two days tho

$BMNU  Watching $24 again. Maybe I’ll sell some against my position, AGAIN. Tiring but it’s working…..

Feed

News

Sentiment

Fundamentals

Info

BMNU T-REX 2X Long BMNR Daily Target ETF

Fundamentals

Latest BMNU News